Skip to main content
. 2016 Aug 29;2016:2053804. doi: 10.1155/2016/2053804

Table 1.

Test Patient results by year Normal range
2010 2012 2015
ESR (mm/Hr) 35 27 30 <30
CRP (mg/L) 1.88 1.92 1.73 0–5
ANA Negative Negative <1 : 20
Anti-DsDNA (U/mL) 18.2 0–20
Anti-Smith antibody (U/mL) <3.1 0–5
Anti-SSA (Ro) antibody (U/mL) <3.1 0–4
Anti-SSB (La) antibody (U/mL) <3.1 0–4
Anti-SCL-70 antibody (U/mL) <3 0–3
C-ANCA (U/mL) <3.1 <3.1 0–10
P-ANCA (U/mL) 3.5 4.8 0–6
Anti-phosphatidylserine IgM and IgG (GPL/mL) Negative Negative 0–10
Anti-B2-glycoprotein IgM and IgG (GPL/mL) Negative Negative 0–12
Anti-cardiolipin IgM and IgG (GPL/mL) Negative Negative <10
Cyclic citrullinated peptide antibody (U/mL) <0.5 <1.0 0–4.9
Rheumatoid factor (IU/mL) 7.4 <10 0–14
Cryoglobulin Absent Absent
Serum protein electrophoresis Normal pattern Normal pattern
Urine protein electrophoresis Normal pattern Normal pattern

ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; ANA: antinuclear antibody; SSA: Sjögren's-syndrome-related antigen A; SSB: Sjögren's-syndrome-related antigen B; SCL: scleroderma; C-ANCA: cytoplasmic antineutrophil cytoplasmic antibodies; P-ANCA: perinuclear antineutrophil cytoplasmic antibodies.